drugset / Trial / NCT00476385
Practicability and Acceptability of Stylomax® in Children
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Primary objective: to evaluate the practicability and acceptability of STYLOMAX®, a new injection device for MAXOMAT®, in children, for 1 year.
Timeline
- Start
- 2003-06
- Primary completion
- 2005-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | SOMATROPINE | Protein / enzyme biologic | 1.04 mg | Subcutaneous |